Yongsung Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yongsung Park has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Wonsuck Yoon
Allergy Immunology Center, Korea University
7 shared publications - Cheol-Won Yun
School of Life Sciences and Biotechnology, Korea University, Anam-dong, Sungbuk-gu, Seoul, Republic of Korea
3 shared publications - Hye-Won Seo
Department of Medical Microbiology and Immunology, University of Wisconsin, Madison, WI 53706, USA
3 shared publications - Seunghyun Kim
Allergy Immunology Center, Korea University, Seoul 02841, Korea
3 shared publications - Suzie Kang
School of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea
3 shared publications - Young Yoo
Department of Pediatrics, Korea University College of Medicine, Seoul
3 shared publications
Latest Publications
- Open Access
- 8 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (4) , 1336
Comparative Investigation of the Effects of Entelon150®, Losartan, and Rosuvastatin Following Subdermal Valve Prosthesis in a Rat Model
Background/Objectives: Entelon150® (Vitis vinifera seed extract), losartan, and rosuvastatin have been shown to be effective in reducing calcification and inflammation of bovine pericardium implants. However, no study has compared the effects of the drugs on bioprosthetic heart valve (BHV). This study aimed to compare the anti-calcification and anti-inflammatory effects of each drug in a rat model. Methods: Twenty-eight female Sprague-Dawley rats (two weeks old) were implanted with BHV leaflets in the dorsal subcutis. They were divided into control, losartan (10.3 mg/kg/day), rosuvastatin (2 mg/kg/day), and Entelon150® (30.8 mg/kg/day) groups. Eight weeks later, the calcium level and inflammatory cell infiltration in the BHV leaflets as well as the expression levels of IL-6, osteopontin, and BMP-2 in the surrounding tissues were measured. Results: Losartan-, Entelon150®-, and rosuvastatin-treated groups showed a decrease in the calcium content as compared to the control group in the order. A reduction in the inflammatory cell infiltration was observed in the treatment groups (losartan > Entelon150® > rosuvastatin) as compared to that in the control group. The treatment groups showed a decrease in IL-6, OPN, and BMP-2 expression levels as compared to the control group in the following order: Entelon150® > losartan > rosuvastatin. Conclusions: The calcification of the BHV leaflets and inflammation of the surrounding tissues in treatment groups were lower than those in the control group and were comparable to each other. Entelon150® showed comparable anti-inflammatory and anti-calcification effects and may represent a potential therapeutic candidate for prolonging BHV durability, although further validation is required.
- 8 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (4) , 1336
Open AccessComparative Investigation of the Effects of Entelon150®, Losartan, and Rosuvastatin Following Subdermal Valve Prosthesis in a Rat Model
Background/Objectives: Entelon150® (Vitis vinifera seed extract), losartan, and rosuvastatin have been shown to be effective in reducing calcification and inflammation of bovine pericardium implants. However, no study has compared the effects of the drugs on bioprosthetic heart valve (BHV). This study aimed to compare the anti-calcification and anti-inflammatory effects of each drug in a rat model. Methods: Twenty-eight female Sprague-Dawley rats (two weeks old) were implanted with BHV leaflets in the dorsal subcutis. They were divided into control, losartan (10.3 mg/kg/day), rosuvastatin (2 mg/kg/day), and Entelon150® (30.8 mg/kg/day) groups. Eight weeks later, the calcium level and inflammatory cell infiltration in the BHV leaflets as well as the expression levels of IL-6, osteopontin, and BMP-2 in the surrounding tissues were measured. Results: Losartan-, Entelon150®-, and rosuvastatin-treated groups showed a decrease in the calcium content as compared to the control group in the order. A reduction in the inflammatory cell infiltration was observed in the treatment groups (losartan > Entelon150® > rosuvastatin) as compared to that in the control group. The treatment groups showed a decrease in IL-6, OPN, and BMP-2 expression levels as compared to the control group in the following order: Entelon150® > losartan > rosuvastatin. Conclusions: The calcification of the BHV leaflets and inflammation of the surrounding tissues in treatment groups were lower than those in the control group and were comparable to each other. Entelon150® showed comparable anti-inflammatory and anti-calcification effects and may represent a potential therapeutic candidate for prolonging BHV durability, although further validation is required.
- Open Access
- 31 December 2025
- Published by Korean Society of Environmental Health in Journal of Environmental Health Sciences
- Vol. 51 (6) , 372-382
AI-Driven Surveillance and Prediction of Indoor Microbial Risks with Climate Change
Wonsuck Yoon, Yongsung Park, Hyosun Lee, and Seunghyun Kim. J Environ Health Sci. 2025;51:372-82. https://doi.org/10.5668/JEHS.2025.51.6.372
- 31 December 2025
- Published by Korean Society of Environmental Health in Journal of Environmental Health Sciences
- Vol. 51 (6) , 372-382
Open AccessAI-Driven Surveillance and Prediction of Indoor Microbial Risks with Climate Change
Wonsuck Yoon, Yongsung Park, Hyosun Lee, and Seunghyun Kim. J Environ Health Sci. 2025;51:372-82. https://doi.org/10.5668/JEHS.2025.51.6.372
- Open Access
- 9 June 2025
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 495, 138884
Assessment of pulmonary toxicity in mice to evaluate human health risks from indoor airborne microorganisms
- 9 June 2025
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 495, 138884
Open AccessAssessment of pulmonary toxicity in mice to evaluate human health risks from indoor airborne microorganisms
- Open Access
- 1 January 2025
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 17 (4) , 460-472
Fungal Microbiome Diversity in Urban Forest Decreases Asthma and Allergic Inflammation
Yoon W, et al. Allergy Asthma Immunol Res. 2025 Jul;17(4):460-472. https://doi.org/10.4168/aair.2025.17.4.460
- 1 January 2025
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 17 (4) , 460-472
Open AccessFungal Microbiome Diversity in Urban Forest Decreases Asthma and Allergic Inflammation
Yoon W, et al. Allergy Asthma Immunol Res. 2025 Jul;17(4):460-472. https://doi.org/10.4168/aair.2025.17.4.460
- Open Access
- 18 November 2024
- Published by MDPI AG in Atmosphere
- Vol. 15 (11) , 1389
Concrete Actions for Improving Indoor Air Quality in Korea: Advancing Public Health for Vulnerable Populations
In modern society, individuals spend an increasing amount of time indoors, emphasizing the importance of understanding the health impacts of indoor environments. This study focused on measuring indoor air quality to identify vulnerable populations and observe the effects of residential environment improvements on air quality. Targeting low-income families and elderly households, known for their heightened vulnerability to environmental health risks, the study involved direct visits to 2328 low-income households across 16 cities and provinces in South Korea from 2021 to 2022. Indoor air quality parameters, including PM2.5, PM10, total volatile organic compounds (TVOC), formaldehyde (HCHO), and airborne mold, were measured. Among these households, 300 with critically compromised living conditions received support for wallpaper and paneling replacement. Comparative measurements before and after the renovations revealed that single-person households had higher levels of PM2.5 and TVOC compared with households with four or more members. Additionally, households with elevated concentrations of airborne mold also exhibited higher levels of PM2.5 and PM10. Importantly, households that received environmental improvements showed a significant reduction in airborne mold concentration by approximately 50% or more. This study underscores the importance of indoor environmental health and provides valuable evidence supporting policies focused on health promotion and residential welfare improvements for vulnerable populations. The research is distinguished by its comprehensive nature, involving direct measurements from nearly 2000 households nationwide, rather than relying solely on secondary data.
- 18 November 2024
- Published by MDPI AG in Atmosphere
- Vol. 15 (11) , 1389
Open AccessConcrete Actions for Improving Indoor Air Quality in Korea: Advancing Public Health for Vulnerable Populations
In modern society, individuals spend an increasing amount of time indoors, emphasizing the importance of understanding the health impacts of indoor environments. This study focused on measuring indoor air quality to identify vulnerable populations and observe the effects of residential environment improvements on air quality. Targeting low-income families and elderly households, known for their heightened vulnerability to environmental health risks, the study involved direct visits to 2328 low-income households across 16 cities and provinces in South Korea from 2021 to 2022. Indoor air quality parameters, including PM2.5, PM10, total volatile organic compounds (TVOC), formaldehyde (HCHO), and airborne mold, were measured. Among these households, 300 with critically compromised living conditions received support for wallpaper and paneling replacement. Comparative measurements before and after the renovations revealed that single-person households had higher levels of PM2.5 and TVOC compared with households with four or more members. Additionally, households with elevated concentrations of airborne mold also exhibited higher levels of PM2.5 and PM10. Importantly, households that received environmental improvements showed a significant reduction in airborne mold concentration by approximately 50% or more. This study underscores the importance of indoor environmental health and provides valuable evidence supporting policies focused on health promotion and residential welfare improvements for vulnerable populations. The research is distinguished by its comprehensive nature, involving direct measurements from nearly 2000 households nationwide, rather than relying solely on secondary data.
- Open Access
Development of an Oral Salmonella-Based Vaccine Platform against SARS-CoV-2
Effective vaccine development for global outbreaks, such as the coronavirus disease 2019 (COVID-19), has been successful in the short run. However, the currently available vaccines have been associated with a higher frequency of adverse effects compared with other general vaccines. In this study, the possibility of an oral bacteria-based vaccine that can be safely used as a platform for large-scale, long-term immunization was evaluated. A well-known Salmonella strain that was previously considered as a vaccine delivery candidate was used. Recombinant Salmonella cells expressing engineered viral proteins related with COVID-19 pathogenesis were engineered, and the formulation of the oral vaccine candidate strain was evaluated by in vitro and in vivo experiments. First, engineered S proteins were synthesized and cloned into expression vectors, which were than transformed into Salmonella cells. In addition, when orally administrated to mice, the vaccine promoted antigen-specific antibody production and cellular immunity was induced with no significant toxicity effects. These results suggest that Salmonella strains may represent a valuable platform for the development of an oral vaccine for COVID-19 as an alternative to tackle the outbreak of various mutated coronavirus strains and new infectious diseases in the future.
Open AccessDevelopment of an Oral Salmonella-Based Vaccine Platform against SARS-CoV-2
Effective vaccine development for global outbreaks, such as the coronavirus disease 2019 (COVID-19), has been successful in the short run. However, the currently available vaccines have been associated with a higher frequency of adverse effects compared with other general vaccines. In this study, the possibility of an oral bacteria-based vaccine that can be safely used as a platform for large-scale, long-term immunization was evaluated. A well-known Salmonella strain that was previously considered as a vaccine delivery candidate was used. Recombinant Salmonella cells expressing engineered viral proteins related with COVID-19 pathogenesis were engineered, and the formulation of the oral vaccine candidate strain was evaluated by in vitro and in vivo experiments. First, engineered S proteins were synthesized and cloned into expression vectors, which were than transformed into Salmonella cells. In addition, when orally administrated to mice, the vaccine promoted antigen-specific antibody production and cellular immunity was induced with no significant toxicity effects. These results suggest that Salmonella strains may represent a valuable platform for the development of an oral vaccine for COVID-19 as an alternative to tackle the outbreak of various mutated coronavirus strains and new infectious diseases in the future.
- Open Access
- 22 November 2021
- Published by MDPI AG in Microorganisms
- Vol. 9 (11) , 2408
Combined Therapy with microRNA-Expressing Salmonella and Irradiation in Melanoma
Anticancer treatment strategies using bacteria as a vector are currently expanding with the development of anticancer drugs. Here, we present a research strategy to develop anticancer drugs using bacteria that contain miRNAs. We also present a strategy for the development of novel bacterial anticancer drugs in combination with radiation. Salmonella strains expressing miRNA were produced by modifying the miRNA expression vector encoding INHA, a radiation-resistant gene developed previously. The anticancer effect of INHA was confirmed using skin cancer cell lines. We also tested a combination strategy comprising bacteria and radiation for its anticancer efficacy against radiation-resistant mouse melanoma to increase the efficacy of radiation therapy as a novel strategy. The recombinant strain was confirmed to promote effective cell death even when combined with radiation therapy, which exerts its cytotoxicity by enhancing reactive oxygen species production. Moreover, a combination of bacterial and radiation therapy enhanced radiotherapy efficacy. When combined with radiation therapy, bacterial therapy exhibited effective anti-cancer properties even when administered to animals harboring radiation-resistant tumors. This strategy may promote the secretion of cytokines in cells and more effectively reduce the number of bacteria remaining in the animal. Thus, this study may lead to the development of a strategy to improve the effectiveness of radiation therapy using Salmonella expressing cancer-specific miRNA for intractable cancers such as those resistant to radiation.
- 22 November 2021
- Published by MDPI AG in Microorganisms
- Vol. 9 (11) , 2408
Open AccessCombined Therapy with microRNA-Expressing Salmonella and Irradiation in Melanoma
Anticancer treatment strategies using bacteria as a vector are currently expanding with the development of anticancer drugs. Here, we present a research strategy to develop anticancer drugs using bacteria that contain miRNAs. We also present a strategy for the development of novel bacterial anticancer drugs in combination with radiation. Salmonella strains expressing miRNA were produced by modifying the miRNA expression vector encoding INHA, a radiation-resistant gene developed previously. The anticancer effect of INHA was confirmed using skin cancer cell lines. We also tested a combination strategy comprising bacteria and radiation for its anticancer efficacy against radiation-resistant mouse melanoma to increase the efficacy of radiation therapy as a novel strategy. The recombinant strain was confirmed to promote effective cell death even when combined with radiation therapy, which exerts its cytotoxicity by enhancing reactive oxygen species production. Moreover, a combination of bacterial and radiation therapy enhanced radiotherapy efficacy. When combined with radiation therapy, bacterial therapy exhibited effective anti-cancer properties even when administered to animals harboring radiation-resistant tumors. This strategy may promote the secretion of cytokines in cells and more effectively reduce the number of bacteria remaining in the animal. Thus, this study may lead to the development of a strategy to improve the effectiveness of radiation therapy using Salmonella expressing cancer-specific miRNA for intractable cancers such as those resistant to radiation.
- Open Access
- 12 August 2021
- Published by MDPI AG in Microorganisms
- Vol. 9 (8) , 1715
Bacterially Delivered miRNA-Mediated Toll-like Receptor 8 Gene Silencing for Combined Therapy in a Murine Model of Atopic Dermatitis: Therapeutic Effect of miRTLR8 in AD
In atopic dermatitis (AD), skin inflammation is caused by complex interactions between genetic disposition and aberrant innate/adaptive immune responses. Toll-like receptors (TLRs) are key molecules in the innate/adaptive immune response as they recognize various molecular motifs associated with pathogens. Among them, TLR8 is implicated in eczematous skin reactions. We investigated the combined therapeutic effects of TLR8 gene silencing by the bacterial delivery of miRNA. We used Salmonella as a vector to deliver TLR8 miRNA. The recombinant strain of Salmonella enterica subsp. enterica serovar Typhimurium (ST) expressing TLR8 miRNA (ST-miRTLR8) was prepared for knockdown of TLR8. After oral administration of ST-miRTLR8 into mice, we observed the cytokine levels, skin pathology and scratching behaviors in an AD-like mouse model. TLR8 down-regulation decreased macrophage-derived chemokine concentrations in activated human mast cells. Serum IgE and interleukin-4 production were suppressed whereas IFN-γ was induced after oral administration of ST-miRTLR8. Scratching behaviors and skin inflammation were also improved. In addition, attenuated S. typhimurium safely accumulated in mouse macrophages and showed adjuvant effects. This study shows that the recombinant miRNA that expresses the TLR8 miRNA has therapeutic effects by suppressing Th2 inflammation. TLR gene modulation using miRNA via Salmonella vectors will thus have a double-protective effect in the treatment of AD.
- 12 August 2021
- Published by MDPI AG in Microorganisms
- Vol. 9 (8) , 1715
Open AccessBacterially Delivered miRNA-Mediated Toll-like Receptor 8 Gene Silencing for Combined Therapy in a Murine Model of Atopic Dermatitis: Therapeutic Effect of miRTLR8 in AD
In atopic dermatitis (AD), skin inflammation is caused by complex interactions between genetic disposition and aberrant innate/adaptive immune responses. Toll-like receptors (TLRs) are key molecules in the innate/adaptive immune response as they recognize various molecular motifs associated with pathogens. Among them, TLR8 is implicated in eczematous skin reactions. We investigated the combined therapeutic effects of TLR8 gene silencing by the bacterial delivery of miRNA. We used Salmonella as a vector to deliver TLR8 miRNA. The recombinant strain of Salmonella enterica subsp. enterica serovar Typhimurium (ST) expressing TLR8 miRNA (ST-miRTLR8) was prepared for knockdown of TLR8. After oral administration of ST-miRTLR8 into mice, we observed the cytokine levels, skin pathology and scratching behaviors in an AD-like mouse model. TLR8 down-regulation decreased macrophage-derived chemokine concentrations in activated human mast cells. Serum IgE and interleukin-4 production were suppressed whereas IFN-γ was induced after oral administration of ST-miRTLR8. Scratching behaviors and skin inflammation were also improved. In addition, attenuated S. typhimurium safely accumulated in mouse macrophages and showed adjuvant effects. This study shows that the recombinant miRNA that expresses the TLR8 miRNA has therapeutic effects by suppressing Th2 inflammation. TLR gene modulation using miRNA via Salmonella vectors will thus have a double-protective effect in the treatment of AD.
- Open Access
- 8 March 2021
- Published by MDPI AG in Journal of Fungi
- Vol. 7 (3) , 190
Identification of the Antidepressant Function of the Edible Mushroom Pleurotus eryngii
Pleurotus eryngii produces various functional molecules that mediate physiological functions in humans. Recently, we observed that P. eryngii produces molecules that have antidepressant functions. An ethanol extract of the fruiting body of P. eryngii was obtained, and the extract was purified by XAD-16 resin using an open column system. The ethanol eluate was separated by HPLC, and the fraction with an antidepressant function was identified. Using LC-MS, the molecular structure of the HPLC fraction with antidepressant function was identified as that of tryptamine, a functional molecule that is a tryptophan derivative. The antidepressant effect was identified from the ethanol extract, XAD-16 column eluate, and HPLC fraction by a serotonin receptor binding assay and a cell-based binding assay. Furthermore, a forced swimming test (FST) showed that the mice treated with purified fractions of P. eryngii exhibited decreased immobility time compared with nontreated mice. From these results, we suggest that the extract of P. eryngii has an antidepressant function and that it may be employed as an antidepressant health supplement.
- 8 March 2021
- Published by MDPI AG in Journal of Fungi
- Vol. 7 (3) , 190
Open AccessIdentification of the Antidepressant Function of the Edible Mushroom Pleurotus eryngii
Pleurotus eryngii produces various functional molecules that mediate physiological functions in humans. Recently, we observed that P. eryngii produces molecules that have antidepressant functions. An ethanol extract of the fruiting body of P. eryngii was obtained, and the extract was purified by XAD-16 resin using an open column system. The ethanol eluate was separated by HPLC, and the fraction with an antidepressant function was identified. Using LC-MS, the molecular structure of the HPLC fraction with antidepressant function was identified as that of tryptamine, a functional molecule that is a tryptophan derivative. The antidepressant effect was identified from the ethanol extract, XAD-16 column eluate, and HPLC fraction by a serotonin receptor binding assay and a cell-based binding assay. Furthermore, a forced swimming test (FST) showed that the mice treated with purified fractions of P. eryngii exhibited decreased immobility time compared with nontreated mice. From these results, we suggest that the extract of P. eryngii has an antidepressant function and that it may be employed as an antidepressant health supplement.
- Open Access
- 16 October 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (20) , 7665
The Role of Zinc in Copper Homeostasis of Aspergillus fumigatus
Copper is an essential metal ion that performs many physiological functions in living organisms. Deletion of Afmac1, which is a copper-responsive transcriptional activator in A. fumigatus, results in a growth defect on aspergillus minimal medium (AMM). Interestingly, we found that zinc starvation suppressed the growth defect of the Δafmac1 strain on AMM. In addition, the growth defect of the Δafmac1 strain was recovered by copper supplementation or introduction of the CtrC gene into the Δafmac1 strain. However, chelation of copper by addition of BCS to AMM failed to recover the growth defect of the Δafmac1 strain. Through Northern blot analysis, we found that zinc starvation upregulated CtrC and CtrA2, which encode membrane copper transporters. Interestingly, we found that the conserved ZafA binding motif 5′-CAA(G)GGT-3′ was present in the upstream region of CtrC and CtrA2 and that mutation of the binding motif led to failure of ZafA binding to the upstream region of CtrC and upregulation of CtrC expression under zinc starvation. Furthermore, the binding activity of ZafA to the upstream region of CtrC was inversely proportional to the zinc concentration, and copper inhibited the binding of ZafA to the upstream region of CtrC under a low zinc concentration. Taken together, these results suggest that ZafA upregulates copper metabolism by binding to the ZafA binding motif in the CtrC promoter region under low zinc concentration, thus regulating copper homeostasis. Furthermore, we found that copper and zinc interact in cells to maintain metal homeostasis.
- 16 October 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (20) , 7665
Open AccessThe Role of Zinc in Copper Homeostasis of Aspergillus fumigatus
Copper is an essential metal ion that performs many physiological functions in living organisms. Deletion of Afmac1, which is a copper-responsive transcriptional activator in A. fumigatus, results in a growth defect on aspergillus minimal medium (AMM). Interestingly, we found that zinc starvation suppressed the growth defect of the Δafmac1 strain on AMM. In addition, the growth defect of the Δafmac1 strain was recovered by copper supplementation or introduction of the CtrC gene into the Δafmac1 strain. However, chelation of copper by addition of BCS to AMM failed to recover the growth defect of the Δafmac1 strain. Through Northern blot analysis, we found that zinc starvation upregulated CtrC and CtrA2, which encode membrane copper transporters. Interestingly, we found that the conserved ZafA binding motif 5′-CAA(G)GGT-3′ was present in the upstream region of CtrC and CtrA2 and that mutation of the binding motif led to failure of ZafA binding to the upstream region of CtrC and upregulation of CtrC expression under zinc starvation. Furthermore, the binding activity of ZafA to the upstream region of CtrC was inversely proportional to the zinc concentration, and copper inhibited the binding of ZafA to the upstream region of CtrC under a low zinc concentration. Taken together, these results suggest that ZafA upregulates copper metabolism by binding to the ZafA binding motif in the CtrC promoter region under low zinc concentration, thus regulating copper homeostasis. Furthermore, we found that copper and zinc interact in cells to maintain metal homeostasis.